New Nordic Equazen, Improves concentration levels in children with ADHD, 180 Chewable Softgels
New Nordic Equazen, Improves concentration levels in children with ADHD, 180 Chewable Softgels
New Nordic Equazen Quick Facts
- Equazen significantly reduces ADHD symptoms in scientific studies
- Improves concentration levels in children and adolescents with ADHD
- Supports cognitive health
- Clinically compared to traditional ADHD treatments
- Delicious strawberry flavoured chewable softgels
New Nordic Equazen vs ADHD Medication
Equazen contains EPA, DHA and GLA in the unique 9:3:1 ratio, which has proven successful in many clinical trials compared to other fish oil formulas. In fact, EQUAZEN is the first supplement, which was compared to ADHD medication. It reduced ADHD symptoms, similar to the effects of medication, especially in the children with the inattentive type. EQUAZEN significantly improves concentration levels in children and adolescents with ADHD, and reduces other symptoms such as inattention and learning difficulties and significantly improves writing and spelling abilities.
What is Equazen?
Equazen is an omega 3 and omega 6-based supplement with the unique 9:3:1 ratio of EPA, DHA and GLA. This supplement, approved by Health Canada and tested in many clinical trials, significantly improves concentration levels in children and adolescents with ADHD, and reduces other symptoms such as inattention, hyperactivity/impulsivity and learning difficulties. After 3 months of treatment children tripled their reading performance and doubled their spelling performance.
New Nordic Equazen Ingredients
EPA
With its strong anti-inflammatory properties, this type of omega-3 protects and enhances nervous function
DHA
The omega-3 oil DHA makes cell membranes more fluid and flexible (which is important for cells to communicate with one another) and is important for brain development
GLA
Derived from primrose oil, the omega-6 oil GLA contributes to reduce inflammation. And because DHA inhibits the body’s GLA production, EQUAZEN adds back GLA to ensure greatest effectiveness.
Original: $22.67
-65%$22.67
$7.93More Images
New Nordic Equazen, Improves concentration levels in children with ADHD, 180 Chewable Softgels
New Nordic Equazen Quick Facts
- Equazen significantly reduces ADHD symptoms in scientific studies
- Improves concentration levels in children and adolescents with ADHD
- Supports cognitive health
- Clinically compared to traditional ADHD treatments
- Delicious strawberry flavoured chewable softgels
New Nordic Equazen vs ADHD Medication
Equazen contains EPA, DHA and GLA in the unique 9:3:1 ratio, which has proven successful in many clinical trials compared to other fish oil formulas. In fact, EQUAZEN is the first supplement, which was compared to ADHD medication. It reduced ADHD symptoms, similar to the effects of medication, especially in the children with the inattentive type. EQUAZEN significantly improves concentration levels in children and adolescents with ADHD, and reduces other symptoms such as inattention and learning difficulties and significantly improves writing and spelling abilities.
What is Equazen?
Equazen is an omega 3 and omega 6-based supplement with the unique 9:3:1 ratio of EPA, DHA and GLA. This supplement, approved by Health Canada and tested in many clinical trials, significantly improves concentration levels in children and adolescents with ADHD, and reduces other symptoms such as inattention, hyperactivity/impulsivity and learning difficulties. After 3 months of treatment children tripled their reading performance and doubled their spelling performance.
New Nordic Equazen Ingredients
EPA
With its strong anti-inflammatory properties, this type of omega-3 protects and enhances nervous function
DHA
The omega-3 oil DHA makes cell membranes more fluid and flexible (which is important for cells to communicate with one another) and is important for brain development
GLA
Derived from primrose oil, the omega-6 oil GLA contributes to reduce inflammation. And because DHA inhibits the body’s GLA production, EQUAZEN adds back GLA to ensure greatest effectiveness.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
New Nordic Equazen Quick Facts
- Equazen significantly reduces ADHD symptoms in scientific studies
- Improves concentration levels in children and adolescents with ADHD
- Supports cognitive health
- Clinically compared to traditional ADHD treatments
- Delicious strawberry flavoured chewable softgels
New Nordic Equazen vs ADHD Medication
Equazen contains EPA, DHA and GLA in the unique 9:3:1 ratio, which has proven successful in many clinical trials compared to other fish oil formulas. In fact, EQUAZEN is the first supplement, which was compared to ADHD medication. It reduced ADHD symptoms, similar to the effects of medication, especially in the children with the inattentive type. EQUAZEN significantly improves concentration levels in children and adolescents with ADHD, and reduces other symptoms such as inattention and learning difficulties and significantly improves writing and spelling abilities.
What is Equazen?
Equazen is an omega 3 and omega 6-based supplement with the unique 9:3:1 ratio of EPA, DHA and GLA. This supplement, approved by Health Canada and tested in many clinical trials, significantly improves concentration levels in children and adolescents with ADHD, and reduces other symptoms such as inattention, hyperactivity/impulsivity and learning difficulties. After 3 months of treatment children tripled their reading performance and doubled their spelling performance.
New Nordic Equazen Ingredients
EPA
With its strong anti-inflammatory properties, this type of omega-3 protects and enhances nervous function
DHA
The omega-3 oil DHA makes cell membranes more fluid and flexible (which is important for cells to communicate with one another) and is important for brain development
GLA
Derived from primrose oil, the omega-6 oil GLA contributes to reduce inflammation. And because DHA inhibits the body’s GLA production, EQUAZEN adds back GLA to ensure greatest effectiveness.
